Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Additive value of transarterial embolization to systemic sirolimus treatment in kaposiform hemangioendothelioma.
Brill R, Uller W, Huf V, Müller-Wille R, Schmid I, Pohl A, Häberle B, Perkowski S, Funke K, Till AM, Lauten M, Neumann J, Güttel C, Heid E, Ziermann F, Schmid A, Hüsemann D, Meyer L, Sporns PB, Schinner R, Schmidt VF, Ricke J, Rössler J, Kapp FG, Wohlgemuth WA, Wildgruber M. Brill R, et al. Among authors: schinner r. Int J Cancer. 2021 May 1;148(9):2345-2351. doi: 10.1002/ijc.33406. Epub 2020 Dec 3. Int J Cancer. 2021. PMID: 33231291 Free article.
Impact of Extrahepatic Metastases on Overall Survival in Patients with Advanced Liver Dominant Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial.
Schütte K, Schinner R, Fabritius MP, Möller M, Kuhl C, Iezzi R, Öcal O, Pech M, Peynircioglu B, Seidensticker M, Sharma R, Palmer D, Bronowicki JP, Reimer P, Malfertheiner P, Ricke J. Schütte K, et al. Among authors: schinner r. Liver Cancer. 2020 Dec;9(6):771-786. doi: 10.1159/000510798. Epub 2020 Nov 11. Liver Cancer. 2020. PMID: 33442545 Free PMC article.
Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial.
Shuen TWH, Alunni-Fabbroni M, Öcal E, Malfertheiner P, Wildgruber M, Schinner R, Pech M, Benckert J, Sangro B, Kuhl C, Gasbarrini A, Chow PKH, Toh HC, Ricke J. Shuen TWH, et al. Among authors: schinner r. Clin Cancer Res. 2022 Sep 1;28(17):3890-3901. doi: 10.1158/1078-0432.CCR-22-0569. Clin Cancer Res. 2022. PMID: 35763041 Free PMC article. Clinical Trial.
Clinical Outcome and Quality of Life of Multimodal Treatment of Extracranial Arteriovenous Malformations: The APOLLON Study Protocol.
Schmidt VF, Masthoff M, Vielsmeier V, Seebauer CT, Cangir Ö, Meyer L, Mükke A, Lang W, Schmid A, Sporns PB, Brill R, Wohlgemuth WA, da Silva NPB, Seidensticker M, Schinner R, Küppers J, Häberle B, Haubner F, Ricke J, Zenker M, Kimm MA, Wildgruber M; APOLLON investigators. Schmidt VF, et al. Among authors: schinner r. Cardiovasc Intervent Radiol. 2023 Jan;46(1):142-151. doi: 10.1007/s00270-022-03296-8. Epub 2022 Oct 19. Cardiovasc Intervent Radiol. 2023. PMID: 36261507 Free PMC article.
Vascular response patterns to targeted therapies in murine breast cancer models with divergent degrees of malignancy.
Hoffmann E, Gerwing M, Krähling T, Hansen U, Kronenberg K, Masthoff M, Geyer C, Höltke C, Wachsmuth L, Schinner R, Hoerr V, Heindel W, Karst U, Eisenblätter M, Maus B, Helfen A, Faber C, Wildgruber M. Hoffmann E, et al. Among authors: schinner r. Breast Cancer Res. 2023 May 23;25(1):56. doi: 10.1186/s13058-023-01658-9. Breast Cancer Res. 2023. PMID: 37221619 Free PMC article.
Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer.
Kästle S, Stechele MR, Richter L, Schinner R, Öcal E, Alunni-Fabbroni M, De Toni E, Corradini S, Seidensticker M, Goldberg SN, Ricke J, Wildgruber M, Kimm MA. Kästle S, et al. Among authors: schinner r. J Cancer Res Clin Oncol. 2023 Sep;149(12):9777-9786. doi: 10.1007/s00432-023-04875-z. Epub 2023 May 29. J Cancer Res Clin Oncol. 2023. PMID: 37247078 Free PMC article.
Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy.
Stechele M, Link H, Hirner-Eppeneder H, Alunni-Fabbroni M, Wildgruber M, Salvermoser L, Corradini S, Schinner R, Ben Khaled N, Rössler D, Galun E, Goldberg SN, Ricke J, Kazmierczak PM. Stechele M, et al. Among authors: schinner r. Radiat Oncol. 2023 Jul 28;18(1):125. doi: 10.1186/s13014-023-02316-2. Radiat Oncol. 2023. PMID: 37507808 Free PMC article.
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial.
Labeur TA, Hofsink Q, Takkenberg RB, van Delden OM, Mathôt RAA, Schinner R, Malfertheiner P, Amthauer H, Schütte K, Basu B, Kuhl C, Mayerle J, Ricke J, Klümpen HJ. Labeur TA, et al. Among authors: schinner r. Acta Oncol. 2020 Sep;59(9):1028-1035. doi: 10.1080/0284186X.2020.1759826. Epub 2020 May 5. Acta Oncol. 2020. PMID: 32366155 Clinical Trial.
NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial.
Geyer T, Rübenthaler J, Alunni-Fabbroni M, Schinner R, Weber S, Mayerle J, Schiffer E, Höckner S, Malfertheiner P, Ricke J. Geyer T, et al. Among authors: schinner r. Cancers (Basel). 2021 Jun 3;13(11):2787. doi: 10.3390/cancers13112787. Cancers (Basel). 2021. PMID: 34205110 Free PMC article.
39 results